Replies to post #166327 on Biotech Values

[DewDiligence]

So does that theoretically cut ENTA's future revenue to 35% of current estimations?

No, of course not. Nobody expected ENTA to receive a royalty from ABBV on the components of ABBV's cocktail not contributed by ENTA.